Maria Ana Hermosilla

Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcoma

Juan Tornín, Lucia Martínez-Cruzado, Laura Santos et al. · Oncotarget · 2016 · 49 citations · Full text

Medicine, Oncology, Pharmacology +14

Inhibition of FLT3 and PIM Kinases by EC-70124 Exerts Potent Activity in Preclinical Models of Acute Myeloid Leukemia

Noelia Puente‐Moncada, Paula Costales, Isaac Antolı́n et al. · Molecular Cancer Therapeutics · 2018 · 24 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042

Francisco Hermida‐Prado, M. Ángeles Villaronga, Rocío Granda‐Díaz et al. · Journal of Clinical Medicine · 2019 · 24 citations · Full text

Medicine, Oncology, Pharmacology +17

The multikinase inhibitor EC‐70124 synergistically increased the antitumor activity of doxorubicin in sarcomas

Óscar Estupiñán, Laura Santos, Aida Rodríguez et al. · International Journal of Cancer · 2018 · 16 citations · Full text

Medicine, Oncology, Pharmacology +14